Adverse pregnancy outcomes among HIV-positive pregnant women treated with efavirenz-containing antiretroviral drugs: a retrospective cohort study in the Cape Flats

Adverse pregnancy outcomes among HIV-positive pregnant women treated with efavirenz-containing antiretroviral drugs: a retrospective cohort study in the Cape Flats

Doctor Pharmaceuticae - Dpharm === The use of efavirenz (EFV) in the first trimester of pregnancy remains controversial. In South Africa, the use of EFV-containing antiretroviral therapy (ART) as part of a Fixed Dose Combination (FDC) during the first trimester of pregnancy started in April, 2013. L...

Full description

Bibliographic Details
Main Author: Mohammednur, Mohammedmekin Mohammedseid
Other Authors: Mugabo, Pierre
Language:en
Published: University of the Western Cape 2018
Subjects:
Adverse pregnancy outcomes
Antiretroviral drug
Birth defect
Efavirenz
First trimester
HIV
Low birth weight
Nevirapine
Pregnant women
Preterm delivery
Online Access:http://hdl.handle.net/11394/6185

Internet

http://hdl.handle.net/11394/6185

Similar Items